Use este identificador para citar ou linkar para este item:
https://www.arca.fiocruz.br/handle/icict/10577
Tipo de documento
ArtigoDireito Autoral
Acesso aberto
Objetivos de Desenvolvimento Sustentável
10 Redução das desigualdadesColeções
Metadata
Mostrar registro completo
AN INTEGRATED MAP OF HIV GENOME-WIDE VARIATION FROM A POPULATION PERSPECTIVE.
Genomic diversity
Conservation
Peptide inhibitor
HIV-human protein interaction
HIV
Phylogenetic tree
HIV inter- and inter-clade genetic diversity
Selective pressure
Protein multimerization
Protein intrinsic disorder
Autor(es)
Afiliação
Central South University. Metabolic Syndrome Research Center. Second Xiangya Hospital. Changsha, Hunan, China / Rega Institute for Medical Research. Department of Microbiology and Immunology. KU Leuven, Leuven, Belgium
Central South University. Metabolic Syndrome Research Center. Second Xiangya Hospital. Changsha, Hunan, China / Rega Institute for Medical Research. Department of Microbiology and Immunology. KU Leuven, Leuven, Belgium
University of Oxford. Department of Zoology. Oxford, UK
RIKEN Institute Laboratories. Zhang IRU. Hirosawa, Wako-shi, Saitama, Japan
Rega Institute for Medical Research. Department of Microbiology and Immunology. KU Leuven, Leuven, Belgium / Universidad del Rosario. Faculty of Sciences and Mathematics. Clinical and Molecular Infectious Disease Group. Bogotá, Colombia
Rega Institute for Medical Research. Department of Microbiology and Immunology. KU Leuven, Leuven, Belgium / Fundação Oswaldo Cruz. Centro de Pesquisas Gonçalo Moniz. Salvador, BA, Brasil
Rega Institute for Medical Research. Department of Microbiology and Immunology. KU Leuven, Leuven, Belgium
Rega Institute for Medical Research. Department of Microbiology and Immunology. KU Leuven, Leuven, Belgium / Universidade Nova de Lisboa. Instituto de Higiene e Medicina Tropical. Centro de Malária e Outras Doenças Tropicais and Unidade de Microbiologia. Lisbon, Portugal
Rega Institute for Medical Research. Department of Microbiology and Immunology. KU Leuven, Leuven, Belgium
Central South University. Metabolic Syndrome Research Center. Second Xiangya Hospital. Changsha, Hunan, China / Rega Institute for Medical Research. Department of Microbiology and Immunology. KU Leuven, Leuven, Belgium
University of Oxford. Department of Zoology. Oxford, UK
RIKEN Institute Laboratories. Zhang IRU. Hirosawa, Wako-shi, Saitama, Japan
Rega Institute for Medical Research. Department of Microbiology and Immunology. KU Leuven, Leuven, Belgium / Universidad del Rosario. Faculty of Sciences and Mathematics. Clinical and Molecular Infectious Disease Group. Bogotá, Colombia
Rega Institute for Medical Research. Department of Microbiology and Immunology. KU Leuven, Leuven, Belgium / Fundação Oswaldo Cruz. Centro de Pesquisas Gonçalo Moniz. Salvador, BA, Brasil
Rega Institute for Medical Research. Department of Microbiology and Immunology. KU Leuven, Leuven, Belgium
Rega Institute for Medical Research. Department of Microbiology and Immunology. KU Leuven, Leuven, Belgium / Universidade Nova de Lisboa. Instituto de Higiene e Medicina Tropical. Centro de Malária e Outras Doenças Tropicais and Unidade de Microbiologia. Lisbon, Portugal
Rega Institute for Medical Research. Department of Microbiology and Immunology. KU Leuven, Leuven, Belgium
Resumo em Inglês
BACKGROUND: The HIV pandemic is characterized by extensive genetic variability, which has challenged the development of HIV drugs and vaccines. Although HIV genomes have been classified into different types, groups, subtypes and recombinants, a comprehensive study that maps HIV genome-wide diversity at the population level is still lacking to date. This study aims to characterize HIV genomic diversity in large-scale sequence populations, and to identify driving factors that shape HIV genome diversity. RESULTS: A total of 2996 full-length genomic sequences from 1705 patients infected with 16 major HIV groups, subtypes and circulating recombinant forms (CRFs) were analyzed along with structural, immunological and peptide inhibitor information. Average nucleotide diversity of HIV genomes was almost 50% between HIV-1 and HIV-2 types, 37.5% between HIV-1 groups, 14.7% between HIV-1 subtypes, 8.2% within individual HIV-1 subtypes and less than 1% within single patients. Along the HIV genome, diversity patterns and compositions of nucleotides and amino acids were highly similar across different groups, subtypes and CRFs. Current HIV-derived peptide inhibitors were predominantly derived from conserved, solvent accessible and intrinsically ordered structures in the HIV-1 subtype B genome. We identified these conserved regions in Capsid, Nucleocapsid, Protease, Integrase, Reverse transcriptase, Vpr and the GP41 N terminus as potential drug targets. In the analysis of factors that impact HIV-1 genomic diversity, we focused on protein multimerization, immunological constraints and HIV-human protein interactions. We found that amino acid diversity in monomeric proteins was higher than in multimeric proteins, and diversified positions were preferably located within human CD4 T cell and antibody epitopes. Moreover, intrinsic disorder regions in HIV-1 proteins coincided with high levels of amino acid diversity, facilitating a large number of interactions between HIV-1 and human proteins. CONCLUSIONS: This first large-scale analysis provided a detailed mapping of HIV genomic diversity and highlighted drug-target regions conserved across different groups, subtypes and CRFs. Our findings suggest that, in addition to the impact of protein multimerization and immune selective pressure on HIV-1 diversity, HIV-human protein interactions are facilitated by high variability within intrinsically disordered structures.
Palavras-chave em inglês
HIV genomeGenomic diversity
Conservation
Peptide inhibitor
HIV-human protein interaction
HIV
Phylogenetic tree
HIV inter- and inter-clade genetic diversity
Selective pressure
Protein multimerization
Protein intrinsic disorder
Compartilhar